Mechanism of Action of Toradol (Ketorolac)
Toradol (ketorolac tromethamine) works primarily by inhibiting both COX-1 and COX-2 enzyme isoforms, thereby blocking prostaglandin synthesis, which is the main mechanism responsible for its analgesic, anti-inflammatory, and antipyretic effects. 1
Primary Mechanism
Ketorolac is a nonsteroidal anti-inflammatory drug (NSAID) that prevents the conversion of arachidonic acid to prostaglandins by inhibiting cyclooxygenase enzymes 2. The drug exists as a racemic mixture of S- and R-enantiomers, with the S-form being responsible for the analgesic activity 1.
COX Enzyme Inhibition
COX-1 inhibition: Ketorolac has high affinity for COX-1, which is constitutively expressed throughout the body and provides routine physiologic functions including gastric mucosal protection and vascular hemostasis 3, 4
COX-2 inhibition: Also inhibits COX-2, which is primarily expressed by inflammatory cells (polymorphonuclear leukocytes and macrophages) in response to inflammatory stimuli 4
Secondary Mechanisms
Beyond prostaglandin synthesis inhibition, ketorolac has additional analgesic mechanisms involving local nitric oxide synthesis 2. This secondary pathway may contribute to its overall analgesic efficacy, though the complete mechanism of action is not fully understood 1.
Clinical Pharmacology Characteristics
- Peak analgesic effect: Occurs within 2-3 hours after administration 1
- No central nervous system effects: Unlike opioids, ketorolac does not bind to opioid receptors and is not a centrally acting agent 5
- No sedative or anxiolytic properties: Provides analgesia without affecting consciousness or causing respiratory depression 1, 6
Important Clinical Distinction
The biological activity is specifically associated with the S-enantiomer form of the racemic mixture 1. This stereospecificity is important for understanding the drug's pharmacodynamic profile and why it functions as a potent analgesic comparable to opioids in certain pain states, despite working through an entirely different mechanism 7, 8.